Find Answers.
Take Action.®Your Essential Partner
in Cancer CareColleen enjoys photography and has been
living with cancer since 2014.
Foundation Medicine is transforming cancer care by providing patients, physicians and researchers with a deep understanding of the genomic mutations that drive cancer.
Proven Leadership
Extensively validated and continuously updated. The validations of our comprehensive genomic profiling services are published in top-tier peer-reviewed journals, and the services are supported by a large and growing body of clinical evidence.1-6 Our continuously growing genomic database currently includes over 800,000 genomic profiles in over 150 common and rare tumour subtypes, helping us to ensure our reporting of clinically-relevant genomic alterations is always up-to-date.7
Valuable Insights, Actionable Options
Our tests help to identify the genomic alterations driving a patient's cancer and match them with relevant targeted therapies, immunotherapies, and clinical trial options.2-4
We also provide decision support services.
Patient Story
Treating cancer means more than just dealing with the disease; it also means treating the whole person. Christine Bray, ovarian cancer survivor, shares her journey to remission after obtaining a Foundation Medicine comprehensive genomic profiling test.
Actionable Insights Upfront
We understand that treatment planning for your cancer patients can be complex. That’s why we have a “Professional Services” summary section to the first page for our FoundationOne CDx and FoundationOne Liquid CDx reports . This will bring information for all reported biomarker and genomic findings and our new “Report Highlights” section upfront, to help you focus on the critical findings for your patients quicker and easier.
ADDITIONAL NOTES
- CDx: Companion Diagnostic, NGS: Next-Generation Sequencing, US: United States.
- * Data on file, Foundation Medicine Inc., data as of Sept. 2024.
- 1 Frampton GM et al. Nat Biotechnol 2013; 31: 1023-1031. https://doi.org/10.1038/nbt.2696 - Accessed on September 26, 2024
- 2 FoundationOne®CDx FDA Approval, 2017. Available at: https://www.accessdata.fda.gov/cdrh_docs/pdf17/P170019a.pdf (Accessed on September 26, 2024).
- 3 FoundationOne Liquid®CDx Technical Specifications, 2020. Available at: https://www.foundationmedicine.qarad.eifu.online/foundationmedicine/en/foundationmedicine (Accessed on September 26, 2024).
- 4 FoundationOne®Heme Technical Specifications, 2019. Available at: https://www.foundationmedicine.qarad.eifu.online/foundationmedicine/en/foundationmedicine (Accessed on September 26, 2024).
- 5 A search for "Foundation Medicine"[Affiliation] on the NCBI database resulted in 1,010 publications as of September 2024. Available at: www.ncbi.nlm.nih.gov/pubmed/?term=%22Foundation+Medicine%22%5BAffiliation%5D (Accessed on September 26, 2024).
- 6 Foundation Medicine Publications. Available at: www.foundationmedicine.com/resources?prod_fmi_sitewide%5Bmenu%5D%5Btype%5D=Publication#no-trail (Accessed on September 26, 2024).
- 7 Foundation Medicine Corporate Fact Sheet, https://www.foundationmedicine.com/sites/default/files/media/documents/2024-08/Foundation_Medicine_Corporate_Fact_Sheet_V19.pdf (Accessed on September 26, 2024)
- 8 FDA List of Cleared or Approved Companion Diagnostic Devices https://www.fda.gov/medical-devices/in-vitro-diagnostics/list-cleared-or-approved-companion-diagnostic-devices-in-vitro-and-imaging-tools (Accessed on October 10, 2024)
- 9 List of approved CDx in Japan https://www.pmda.go.jp/english/rs-sb-std/rs/0006.html (Accessed on October 10, 2024)